ClinicalTrials.govpublic full text
Erlotinib and Sirolimus for the Treatment of Metastatic Renal Cell Carcinoma
renal cell carcinoma, carcinoma, renal cell, receptor, epidermal growth factor, mtor protein, sirolimus, erlotinib, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 848919
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.